Gavi's strategy for 2016-2020 includes an explicit goal to shape markets for vaccines and other immunisation products
Gavi plays an active role in promoting innovation, affordability and supply continuity in the global market for vaccines and other immunisation-related products. In doing so, we aim to help lower-income countries to access secure and sufficient supply of quality products at appropriate and sustainable prices.
Supply and procurement strategy
In June 2016, the Gavi Board approved a new supply and procurement strategy for the 2016–2020 period.
The new strategy takes a long-term approach to creating healthy markets, focusing particularly on creating the conditions necessary for countries to successfully transition out of our support. It also defines a greater role for Gavi in product innovation, and calls for stronger collaboration with vaccine manufacturers.
The objectives of the strategy are:
- ensure sufficient and secure supply;
- reduce costs to an appropriate and sustainable level; and
- incentivise development of innovative, quality products.
Gavi recognises the importance of timely, transparent and accurate information sharing on expected vaccine demand and supply dynamics. We continue to publish awarded prices, public roadmaps and UNICEF market updates.